We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.35 | 1.30 | 1.40 | 1.35 | 1.35 | 1.35 | 130,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.86 | 1.83M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/2/2018 10:32 | So sell all you AIM shares. Will you? | icejelly | |
09/2/2018 10:29 | Most AIM will | volsung | |
09/2/2018 10:27 | Possible a bear market coming - if you talk yourself into it. Not all companies will go down because of a bear market. | icejelly | |
09/2/2018 10:24 | People will sell any AIM bluesky in this market if there's a bit of news. We probably are entering a bear market | volsung | |
09/2/2018 10:18 | Surprise....not | volsung | |
09/2/2018 10:16 | Go8ng down on great news. Bloody aim | spacedust | |
09/2/2018 09:25 | The other thing is if we had a run-rate loss of c. £0.4m on £0.2m revenue base with a revenue base now approaching possibly £0.8m we are not only breakeven but I expect close to profitability of course we all should have known PYC have serious momentum now... they are recruiting | the stigologist | |
09/2/2018 09:12 | Numbers speak. Good post by Stig. Puts things into perspective. Go troll somewhere else mate. | patientcapital | |
09/2/2018 09:07 | Contrary to what you think its not Millen running the show its Harper. Millen like all those before him will be replaced in good time. | pwhite73 | |
09/2/2018 09:06 | #PYC Physiomics 📈 Look at REVENUE line. c.£200k every year BUT in last few months PYC announced :- £500k contract with Merck £30k contract with A.N.Other Major Pharma £70k contract with A.N.Other Major Pharma + expecting news on follow up to £200k Govt grant TRANSFORMATIONAL | the stigologist | |
09/2/2018 09:03 | Can't recall seeing Millen's name mentioned 14 years ago. Wake up ffs. | patientcapital | |
09/2/2018 08:59 | patientcapital PYC have signed more deals with unknown major top 10 global pharmas than there are Kentucky Fried Chicken shops. If you have the time go back over the 14 years and read how many times a new major client has been signed up | pwhite73 | |
09/2/2018 08:54 | "further major (global top-10) pharmaceutical client"i.e. not existing. You deserve some serious smogging pwhite but I'm on iPad so you are lucky. | patientcapital | |
09/2/2018 08:40 | Margic - "This must be the GSK deal. They mention it's a top 10. Not just a major." Glaxo is not in the global top 10 of drug companies. The contract is likely to part of the overall Merck £500k contract awarded in stages. Merck is not just one company it is a group of companies. The fact that they say the contract is expected be completed with the current financial year suggests it is well underway. There is only four months left until June 2018. | pwhite73 | |
09/2/2018 08:06 | Becoming. Industry. Standard. | the stigologist | |
09/2/2018 08:01 | VAL next!!!!! | cudmore | |
09/2/2018 07:56 | Very good news: Sp has held particularly well recently, despite some big sells the other day. Someone knew this contract was coming. Excellent rns, the monetary value 75K is irrelevant, it's the contract itself that is highly significant and further indication of strong confidence in the company and the massive potential. | minja19 | |
09/2/2018 07:51 | Moreover our CEO is delivering on his promises | zebbo | |
09/2/2018 07:49 | This must be the GSK deal. They mention it's a top 10. Not just a major. | margic | |
09/2/2018 07:49 | Another contract that will be complete before June. Nice. | margic |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions